| 1. |  5QBD-Biotech Aydat, France | CRO | Service Provider | VIEW |
| 2. |  Aardvark Therapeutics San Diego, USA | Biotech | Phase 3 | VIEW |
| 3. |  Acadia Pharmaceuticals Inc. San Diego, USA | Biotech | Commercial | VIEW |
| 4. |  Actaros London, United Kingdom | CRO | Commercial | VIEW |
| 5. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 6. |  Agios Pharmaceuticals Cambridge, USA | Biotech | Commercial | VIEW |
| 7. |  Agomab Therapeutics Antwerp, Belgium | Biotech | Phase 2 | VIEW |
| 8. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 9. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 10. |  Ajou University Suwon, South Korea | Biotech | Phase 3 | VIEW |
| 11. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 12. |  | CDMO | Commercial | VIEW |
| 13. |  Alkeus Pharmaceuticals Cambridge, USA | Biotech | Phase 3 | VIEW |
| 14. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 15. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 16. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 17. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 18. |  | CRO | Commercial | VIEW |
| 19. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 20. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 21. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 22. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 23. |  BRIM Biotechnology, Inc. Taipei, Taiwan | Biotech | Phase 3 | VIEW |
| 24. |  | Pharma | Discovery through Commercial | VIEW |
| 25. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 26. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 27. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 28. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 29. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 30. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 31. |  CEVA Logistics Marseille, France | CRO | Commercial | VIEW |
| 32. |  CMC Pharmaceuticals Solon, Ohio, USA | CDMO | Commercial | VIEW |
| 33. |  | Digital Health | Commercial | VIEW |
| 34. |  Carbogen Amcis Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 35. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 36. |  Cellares South San Francisco, USA | CDMO | Commercial | VIEW |
| 37. |  Cencora Conshohocken, Pennsylvania, USA | Pharma | Commercial | VIEW |
| 38. |  Cencora Conshohocken, Pennsylvania, United States | Pharma | Commercial (as distributor/logistics provider) | VIEW |
| 39. |  Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong | Biotech | Preclinical | VIEW |
| 40. |  Centogene Rostock, Germany | Diagnostics | Preclinical | VIEW |
| 41. |  Cerbios-Pharma SA Barbengo-Lugano, Switzerland | CDMO | Preclinical|Clinical|Commercial | VIEW |
| 42. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 43. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 44. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 45. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 46. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 47. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 48. |  City of Hope Duarte, California, USA | Biotech | Commercial | VIEW |
| 49. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 50. |  Clinical2Digital San Diego, USA | Digital Health | Commercial | VIEW |
| 51. |  Codexis, Inc. Redwood City, California, USA | Biotech | Commercial | VIEW |
| 52. |  Curatis Liestal, Switzerland | Biotech | Phase 3 | VIEW |
| 53. |  CureVac TĂĽbingen, Germany | Biotech | Phase 2 | VIEW |
| 54. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 55. |  Cuttsy+Cuttsy Cambridge, United Kingdom | CRO | N/A (Service Provider) | VIEW |
| 56. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 57. |  | CRO | Service Provider | VIEW |
| 58. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 59. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 60. |  Cytochroma Edinburgh, United Kingdom | Biotech | Discovery | VIEW |
| 61. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 62. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 63. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 64. |  | Biotech | Phase I/II - Phase II | VIEW |
| 65. |  Daicel Chiral Technologies Hyderabad, India (Regional HQ); West Chester, PA, USA (Global HQ) | CDMO | Commercial | VIEW |
| 66. |  | CRO | Commercial | VIEW |
| 67. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 68. |  ENGEDI RX Roswell, Georgia, USA | CRO | Commercial | VIEW |
| 69. |  ETH ZĂĽrich Zurich, Switzerland | Biotech | Discovery | VIEW |
| 70. |  EVERSANA Chicago, Illinois, USA | CRO | Commercial | VIEW |
| 71. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 72. |  Ecolab Inc. Saint Paul, USA | Pharma | Commercial | VIEW |
| 73. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 74. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 75. |  | Biotech | Clinical | VIEW |
| 76. |  | Biotech | Preclinical | VIEW |
| 77. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 78. |  Esteve Healthcare Barcelona, Spain | Pharma | Commercial | VIEW |
| 79. |  European Medicines BV Lelystad, Netherlands | CRO | Commercial | VIEW |
| 80. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 81. |  Evolution Health Group, LLC Pearl River, New York, USA | CRO | Commercial | VIEW |
| 82. |  Exeltis Florham Park, USA (Global HQ in Madrid, Spain) | Biotech | Commercial | VIEW |
| 83. |  | CDMO | Commercial | VIEW |
| 84. |  FFF Enterprises, Inc. Temecula, USA | CDMO | Commercial | VIEW |
| 85. |  | Pharma | Commercial | VIEW |
| 86. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 87. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 88. |  Forma Therapeutics Inc Watertown, USA | Biotech | Phase 3 | VIEW |
| 89. |  | Digital Health | Commercial | VIEW |
| 90. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 91. |  | Digital Health | Commercial | VIEW |
| 92. |  George Mason University Fairfax, USA | Biotech | Phase 2 | VIEW |
| 93. |  Global Life Sciences Alliance Philadelphia, PA, USA | CRO | Commercial | VIEW |
| 94. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 95. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 96. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 97. |  Hamad Bin Khalifa University (HBKU) Doha, Qatar | Biotech | Preclinical | VIEW |
| 98. |  Haymarket Media Group London, United Kingdom | Digital Health | Commercial | VIEW |
| 99. |  | Digital Health | Commercial | VIEW |
| 100. |  Heligenics Phoenix, Arizona, USA | Biotech | Discovery | VIEW |
| 101. |  Helix RA Mexico City, Mexico | CRO | Commercial | VIEW |
| 102. |  Hevolution Foundation Riyadh, Saudi Arabia | Biotech | Discovery | VIEW |
| 103. |  Holostem S.r.l. Modena, Italy | Biotech | Commercial | VIEW |
| 104. |  | Digital Health | Commercial | VIEW |
| 105. |  Hospital Israelita Albert Einstein SĂŁo Paulo, Brazil | Diagnostics | Commercial | VIEW |
| 106. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 107. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 108. |  Idorsia Allschwil, Switzerland | Biotech | Commercial | VIEW |
| 109. |  Immorna Biotherapeutics Morrisville, USA | Biotech | Phase 2 | VIEW |
| 110. |  Initial Therapeutics South San Francisco, USA | Biotech | Discovery | VIEW |
| 111. |  | CRO | Commercial | VIEW |
| 112. |  Intellia Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 113. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 114. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 115. |  Ipsen Boulogne-Billancourt, France | Pharma | Commercial | VIEW |
| 116. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 117. |  JW Pharmaceutical Gwacheon, South Korea | Pharma | Commercial | VIEW |
| 118. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 119. |  Kapadi Raleigh, North Carolina, USA | CRO | Commercial | VIEW |
| 120. |  Katrina Rogers Consulting LLC Spokane, Washington, USA | CRO | Commercial | VIEW |
| 121. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 122. |  Kiniksa Pharmaceuticals London, United Kingdom | Biotech | Commercial | VIEW |
| 123. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 124. |  Kyung Hee University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 125. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 126. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 127. |  Laboratorios BagĂł Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 128. |  Lexbridge Co., Ltd. Sakai, Osaka, Japan | CRO | Commercial | VIEW |
| 129. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 130. |  Link Innovations Bengaluru, India | Digital Health | Commercial | VIEW |
| 131. |  | CDMO | Commercial | VIEW |
| 132. |  MARS Group Inc. Bloomington, Illinois, USA | CRO | Commercial | VIEW |
| 133. |  MRH Regulatory Sciences San Francisco, USA | CRO | Commercial | VIEW |
| 134. |  Macrogen Europe Amsterdam, Netherlands | CRO | Commercial | VIEW |
| 135. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 136. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 137. |  Menarini Stemline New York, USA | Biotech | Commercial | VIEW |
| 138. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 139. |  Mersana Therapeutics Cambridge, USA | Biotech | Phase 1 | VIEW |
| 140. |  MetaQ Trials Tel Aviv, Israel | Digital Health | Commercial | VIEW |
| 141. |  Metagenomi Emeryville, USA | Biotech | Preclinical | VIEW |
| 142. |  | Biotech | Preclinical | VIEW |
| 143. |  Mirum Pharmaceuticals Foster City, USA | Biotech | Commercial | VIEW |
| 144. |  | Biotech | Commercial | VIEW |
| 145. |  Mogam Institute for Biomedical Research Seoul, South Korea | Biotech | Discovery|Preclinical | VIEW |
| 146. |  | CRO | Commercial | VIEW |
| 147. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 148. |  | Biotech | Preclinical | VIEW |
| 149. |  Neurocrine Biosciences San Diego, USA | Biotech | Commercial | VIEW |
| 150. |  Neurogene Inc. New York, NY | Biotech | Phase 2 | VIEW |
| 151. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 152. |  Novo Nordisk Bagsværd, Denmark | Pharma | Commercial | VIEW |
| 153. |  Null Hypothesis Hangzhou, China | Digital Health | Commercial | VIEW |
| 154. |  OPIS (a KCR Group Company) Desio (Milan), Italy | CRO | Commercial | VIEW |
| 155. |  Oceanus Plus Beijing, China | Digital Health | Commercial | VIEW |
| 156. |  On/Off Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 157. |  Oncotelic Therapeutics Agoura Hills, California, USA | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 158. |  Optum Eden Prairie, Minnesota, USA | Digital Health | Commercial | VIEW |
| 159. |  Oracle Corporation Austin, Texas, USA | Pharma | Commercial | VIEW |
| 160. |  Orchard Therapeutics London, United Kingdom | Biotech | Commercial | VIEW |
| 161. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 162. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 163. |  PBS Regulatory Consulting Bridgewater, New Jersey, USA | CRO | Commercial | VIEW |
| 164. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 165. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 166. |  Partex NV Eschborn, Germany | Biotech | Phase 2 | VIEW |
| 167. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 168. |  PicnicHealth San Francisco, USA | Digital Health | Commercial | VIEW |
| 169. |  Pierre Fabre Group Castres, France | Pharma | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 170. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 171. |  Precision Medicine Group Bethesda, USA | CRO | Commercial | VIEW |
| 172. |  Precision for Medicine Bethesda, Maryland, USA | CRO | Commercial | VIEW |
| 173. |  Recordati S.p.A. Milan, Italy | Pharma | Commercial | VIEW |
| 174. |  | Diagnostics | Commercial | VIEW |
| 175. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 176. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 177. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 178. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 179. |  Saol Therapeutics Roswell, USA | Biotech | Phase 3 | VIEW |
| 180. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 181. |  StemSynergy Therapeutics Miami, Florida, USA | Biotech | Preclinical and IND-enabling | VIEW |
| 182. |  Stoke Therapeutics Bedford, USA (Moving to Waltham, MA in late 2026) | Biotech | Phase 3 | VIEW |
| 183. |  Sumitomo Pharma America, Inc. Marlborough, USA | Pharma | Commercial | VIEW |
| 184. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 185. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 186. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 187. |  Tanabe Pharma Corporation Osaka, Japan | Pharma | Commercial | VIEW |
| 188. |  Tata Consultancy Services Mumbai, India | CRO | Commercial | VIEW |
| 189. |  Technology Resources, Inc. West Chester, Pennsylvania, USA | CRO | Commercial | VIEW |
| 190. |  The ConfluenceElite Group, LLC Greater Philadelphia Area, USA | CRO | Commercial | VIEW |
| 191. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 192. |  Travalcon Scarborough, Canada | Digital Health | Commercial | VIEW |
| 193. |  TrialBlaze Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 194. |  UK Biobank Stockport, United Kingdom | Diagnostics | Commercial | VIEW |
| 195. |  Ultragenyx Pharmaceutical Inc. Novato, USA | Biotech | Commercial | VIEW |
| 196. |  University of British Columbia Vancouver, Canada | Biotech | Discovery | VIEW |
| 197. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 198. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 199. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 200. |  University of Essex Colchester, United Kingdom | Biotech | Discovery | VIEW |
| 201. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 202. |  Value Genome LLC Exton, Pennsylvania, USA | CRO | Commercial | VIEW |
| 203. |  VitalStage Ventures San Francisco, USA | Digital Health | Commercial | VIEW |
| 204. |  Whyze Health Dublin, Ireland | Digital Health | Commercial | VIEW |
| 205. |  WriteSource Medical Pty Ltd North Sydney, Australia | CRO | Commercial | VIEW |
| 206. |  X4 Pharmaceuticals Boston, USA | Biotech | Commercial | VIEW |
| 207. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |